axitinib: unraveling its mechanism of action, life-changing uses, and side effects
Published 1 year ago • 484 plays • Length 8:32Download video MP4
Download video MP3
Similar videos
-
1:12
dr. rini describes axitinib's and sorafenib's side effects
-
2:32
avelumab plus axitinib improves survival in advanced renal-cell carcinoma patients
-
2:10
inlyta (axitinib)- advanced renal cell carcinoma (rcc)
-
9:30
study on avelumab and axitinib vs sunitinib in the treatment of advanced renal cell carcinoma
-
2:31
axitinib plus pembrolizumab in advanced rcc
-
6:30
inlyta (axitinib) - drug rx information
-
0:57
avelumab and axitinib for the treatment of advanced rcc
-
2:16
treating kidney cancer with axitinib &avelumab, or axitinib & pembrolizumab?
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
0:38
dr. rini explains the axitinib integration process
-
11:56
axitinib is the new standard of care in 2nd-line: pro brian i. rini, m.d.
-
1:19
dr. rini on the efficacy of axitinib and pembrolizumab in rcc
-
1:03
dr. rini on managing the toxicity of pembrolizumab plus axitinib in mrcc
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
9:52
phase 3 axitinib data in patients with previously treated advanced renal cell carcinoma
-
7:42
dalantercept plus axitinib versus placebo plus axitinib in advanced clear cell renal cell carcinoma
-
2:20
the multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treat
-
4:25
kidney cancer updates: avelumab/axitinib, pembro/axitinib, bevacizumab/atezo & ipilimumab/nivo
-
8:50
updated results of a clinical trial evaluating pembrolizumab axitinib for frontline adv rcc